STAT1 contributes to HLA class I upregulation and CTL reactivity after anti-EGFR mAb cetuximab therapy in head and neck cancer patients

Srivastava, Raghvendra M and Jie, Hyun-bae and Ferrone, Soldano and Ferris, Robert L (2013) STAT1 contributes to HLA class I upregulation and CTL reactivity after anti-EGFR mAb cetuximab therapy in head and neck cancer patients. Journal for ImmunoTherapy of Cancer, 1 (S1).

Preview	PDF Published Version Available under License : See the attached license file. Download (212kB) | Preview
	Plain Text (licence) Available under License : See the attached license file. Download (1kB)

---

Share

Citation/Export:	Select format... Citation - Text Citation - HTML Endnote BibTex Dublin Core OpenURL MARC (ISO 2709) METS MODS EP3 XML Reference Manager Refer
Social Networking:	Share |

---

Details

Item Type:	Article
Status:	Published
Creators/Authors:	Creators Email Pitt Username ORCID Srivastava, Raghvendra M rms100@pitt.edu RMS100 Jie, Hyun-bae Ferrone, Soldano Ferris, Robert L
Date:	November 2013
Date Type:	Publication
Journal or Publication Title:	Journal for ImmunoTherapy of Cancer
Volume:	1
Number:	S1
Publisher:	BMJ
DOI or Unique Handle:	10.1186/2051-1426-1-s1-p175
Schools and Programs:	School of Medicine > Immunology School of Medicine > Otolaryngology School of Medicine > Surgery
Refereed:	Yes
Date Deposited:	02 Dec 2016 17:40
Last Modified:	05 Aug 2020 00:55
URI:	http://d-scholarship.pitt.edu/id/eprint/29650

---

Metrics

Monthly Views for the past 3 years

Plum Analytics

Altmetric.com

---

Actions (login required)

View Item